These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

341 related items for PubMed ID: 15036680

  • 1. Long-term safety and tolerability of tadalafil in the treatment of erectile dysfunction.
    Montorsi F, Verheyden B, Meuleman E, Jünemann KP, Moncada I, Valiquette L, Casabé A, Pacheco C, Denne J, Knight J, Segal S, Watkins VS.
    Eur Urol; 2004 Mar; 45(3):339-44; discussion 344-5. PubMed ID: 15036680
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of tadalafil in a Western European population of men with erectile dysfunction.
    Eardley I, Gentile V, Austoni E, Hackett G, Lembo D, Wang C, Beardsworth A.
    BJU Int; 2004 Oct; 94(6):871-7. PubMed ID: 15476525
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of the efficacy and safety of once-a-day dosing of tadalafil 5mg and 10mg in the treatment of erectile dysfunction: results of a multicenter, randomized, double-blind, placebo-controlled trial.
    Porst H, Giuliano F, Glina S, Ralph D, Casabé AR, Elion-Mboussa A, Shen W, Whitaker JS.
    Eur Urol; 2006 Aug; 50(2):351-9. PubMed ID: 16766116
    [Abstract] [Full Text] [Related]

  • 4. Tadalafil improved erectile function at twenty-four and thirty-six hours after dosing in men with erectile dysfunction: US trial.
    Young JM, Feldman RA, Auerbach SM, Kaufman JM, Garcia CS, Shen W, Murphy AM, Beasley CM, Hague JA, Ahuja S.
    J Androl; 2005 Aug; 26(3):310-8. PubMed ID: 15866997
    [Abstract] [Full Text] [Related]

  • 5. Cardiovascular safety update of Tadalafil: retrospective analysis of data from placebo-controlled and open-label clinical trials of Tadalafil with as needed, three times-per-week or once-a-day dosing.
    Kloner RA, Jackson G, Hutter AM, Mittleman MA, Chan M, Warner MR, Costigan TM, Vail GM.
    Am J Cardiol; 2006 Jun 15; 97(12):1778-84. PubMed ID: 16765134
    [Abstract] [Full Text] [Related]

  • 6. Efficacy, safety, and treatment satisfaction of tadalafil versus placebo in patients with erectile dysfunction evaluated at tertiary-care academic centers.
    Carson C, Shabsigh R, Segal S, Murphy A, Fredlund P, Kuepfer C, Trial Evaluating the Activity of Tadalafil for Erectile Dysfunction-United States (TREATED-US) Study Group.
    Urology; 2005 Feb 15; 65(2):353-9. PubMed ID: 15708052
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of on demand tadalafil in the treatment of East and Southeast Asian men with erectile dysfunction: a randomized double-blind, parallel, placebo-controlled clinical study.
    Yip WC, Chiang HS, Mendoza JB, Tan HM, Li MK, Wang WC, Kopernicky V.
    Asian J Androl; 2006 Nov 15; 8(6):685-92. PubMed ID: 16855765
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of tadalafil in men with erectile dysfunction following spinal cord injury.
    Giuliano F, Sanchez-Ramos A, Löchner-Ernst D, Del Popolo G, Cruz N, Leriche A, Lombardi G, Reichert S, Dahl P, Elion-Mboussa A, Casariego J.
    Arch Neurol; 2007 Nov 15; 64(11):1584-92. PubMed ID: 17846260
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of tadalafil once daily in men with diabetes mellitus and erectile dysfunction.
    Hatzichristou D, Gambla M, Rubio-Aurioles E, Buvat J, Brock GB, Spera G, Rose L, Lording D, Liang S.
    Diabet Med; 2008 Feb 15; 25(2):138-46. PubMed ID: 18290855
    [Abstract] [Full Text] [Related]

  • 10. The efficacy and safety of tadalafil in United States and Puerto Rican men with erectile dysfunction.
    Seftel AD, Wilson SK, Knapp PM, Shin J, Wang WC, Ahuja S.
    J Urol; 2004 Aug 15; 172(2):652-7. PubMed ID: 15247754
    [Abstract] [Full Text] [Related]

  • 11. Tadalafil for treatment of erectile dysfunction in men on antidepressants.
    Segraves RT, Lee J, Stevenson R, Walker DJ, Wang WC, Dickson RA.
    J Clin Psychopharmacol; 2007 Feb 15; 27(1):62-6. PubMed ID: 17224715
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of on-demand tadalafil for the treatment of erectile dysfunction in South-East Asian men.
    Guo YL, Zhu JC, Pan TM, Ding Q, Wang YX, Cheong NF, Lim E, Shen W, Venugopalan M, Chan M.
    Int J Urol; 2006 Jun 15; 13(6):721-7. PubMed ID: 16834650
    [Abstract] [Full Text] [Related]

  • 13. Factors associated with preference for sildenafil citrate and tadalafil for treating erectile dysfunction in men naïve to phosphodiesterase 5 inhibitor therapy: post hoc analysis of data from a multicentre, randomized, open-label, crossover study.
    Eardley I, Montorsi F, Jackson G, Mirone V, Chan ML, Loughney K, Vail GM, Beardsworth A.
    BJU Int; 2007 Jul 15; 100(1):122-9. PubMed ID: 17552960
    [Abstract] [Full Text] [Related]

  • 14. A 6-month study of the efficacy and safety of tadalafil in the treatment of erectile dysfunction: a randomised, double-blind, parallel-group, placebo-controlled study in Australian men.
    McMahon CG, Stuckey BG, Lording DW, Wittert GA, Murphy A, Shin J, Sutherland PD, Palmer NR, Lowy MP, Jesudason DR, Fredlund P.
    Int J Clin Pract; 2005 Feb 15; 59(2):143-9. PubMed ID: 15854188
    [Abstract] [Full Text] [Related]

  • 15. A randomized, double-blind, placebo-controlled, cross-over study to assess the efficacy of tadalafil (Cialis) in the treatment of erectile dysfunction following three-dimensional conformal external-beam radiotherapy for prostatic carcinoma.
    Incrocci L, Slagter C, Slob AK, Hop WC.
    Int J Radiat Oncol Biol Phys; 2006 Oct 01; 66(2):439-44. PubMed ID: 16965992
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and treatment satisfaction with on-demand tadalafil (Cialis) in men with erectile dysfunction.
    Skoumal R, Chen J, Kula K, Breza J, Calomfirescu N, Basson BR, Kopernicky V.
    Eur Urol; 2004 Sep 01; 46(3):362-9; discussion 369. PubMed ID: 15306109
    [Abstract] [Full Text] [Related]

  • 17. An evaluation of semen characteristics in men 45 years of age or older after daily dosing with tadalafil 20mg: results of a multicenter, randomized, double-blind, placebo-controlled, 9-month study.
    Hellstrom WJ, Gittelman M, Jarow J, Steidle C, McMurray J, Talley D, Watts S, Mitchell CL, McGill JM.
    Eur Urol; 2008 May 01; 53(5):1058-65. PubMed ID: 17945409
    [Abstract] [Full Text] [Related]

  • 18. Likelihood of tadalafil-associated adverse events in integrated multiclinical trial database: classification tree analysis in men with erectile dysfunction.
    Brock G, Glina S, Moncada I, Watts S, Xu L, Wolka A, Kopernicky V.
    Urology; 2009 Apr 01; 73(4):756-61. PubMed ID: 19193420
    [Abstract] [Full Text] [Related]

  • 19. The effect of tadalafil on psychosocial outcomes in Swedish men with erectile distress: a multicentre, non-randomised, open-label clinical study.
    Fugl-Meyer KS, Stothard D, Belger M, Toll A, Berglund O, Eliasson T, Fugl-Meyer AR.
    Int J Clin Pract; 2006 Nov 01; 60(11):1386-93. PubMed ID: 17073836
    [Abstract] [Full Text] [Related]

  • 20. The efficacy and safety of tadalafil: an update.
    Carson CC, Rajfer J, Eardley I, Carrier S, Denne JS, Walker DJ, Shen W, Cordell WH.
    BJU Int; 2004 Jun 01; 93(9):1276-81. PubMed ID: 15180622
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.